21h
Zacks.com on MSNIs it Worth Retaining QIAGEN Stock in Your Portfolio Now?QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...
For more information, contact [email protected]. All ELI students from a country that has been identified as high-risk must be tested for Tuberculosis using the Quantiferon test before coming to ...
5d
Zacks.com on MSNQiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results